{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:06:09Z","timestamp":1791295569249,"version":"4.1.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Mineralocorticoid receptor (MR) antagonists improve cardiovascular outcomes in patients with heart failure complicating acute myocardial infarction (AMI) and in chronic heart failure. It is unclear whether these beneficial effects are due solely to aldosterone blockade, as MR has a similar affinity for cortisol. We examined the relationships between plasma and urinary steroid hormones and left ventricular (LV) remodelling in patients with LV dysfunction following AMI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Plasma concentrations of renin, aldosterone, and N-terminal pro-brain natriuretic peptide (NT-proBNP), and 24 h urinary excretion rates of tetrahydroaldosterone (THAldo) and total cortisol metabolites were measured in 93 patients at a mean of 46 h following AMI prior to contrast-enhanced cardiac magnetic resonance (ceCMR). Patients were then randomized to 24 weeks of placebo or eplerenone therapy in addition to standard treatment, after which ceCMR was repeated. In placebo-treated patients, aldosterone, NT-proBNP, and excretion rates of THAldo and total cortisol metabolites were univariate predictors of remodelling (i.e. change in LV end-systolic volume index); aldosterone (P = 0.040) and total cortisol metabolite excretion (P = 0.038) remained independent predictors on multivariate analysis. None of the measured biomarkers predicted remodelling in the presence of eplerenone. Plasma and urinary aldosterone measures, and urinary cortisol metabolites, were not only related to larger infarct volumes and greater infarct remodelling over time, but were also higher in patients with microvascular obstruction on baseline ceCMR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Aldosterone and cortisol are associated with medium-term LV remodelling when measured early after AMI. The beneficial effects of MR antagonism may relate to blockade of both aldosterone- and cortisol-induced MR activation.<\/jats:p>\n                    <jats:p>https:\/\/ClinicalTrials.gov: NCT00132093<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurjhf\/hfr129","type":"journal-article","created":{"date-parts":[[2011,9,23]],"date-time":"2011-09-23T20:31:00Z","timestamp":1316809860000},"page":"1305-1313","source":"Crossref","is-referenced-by-count":45,"title":["Aldosterone and Cortisol Predict Medium-Term Left Ventricular Remodelling Following Myocardial Infarction"],"prefix":"10.1093","volume":"13","author":[{"given":"Robin A.P.","family":"Weir","sequence":"first","affiliation":[{"name":"Cardiology Department, Western Infirmary , Glasgow, G11 6NT ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis K.","family":"Tsorlalis","sequence":"additional","affiliation":[{"name":"BHF Cardiovascular Research Centre, University of Glasgow \u00a0","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey","family":"Steedman","sequence":"additional","affiliation":[{"name":"Cardiology Department, Western Infirmary , Glasgow, G11 6NT ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry J.","family":"Dargie","sequence":"additional","affiliation":[{"name":"Cardiology Department, Western Infirmary , Glasgow, G11 6NT ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Fraser","sequence":"additional","affiliation":[{"name":"BHF Cardiovascular Research Centre, University of Glasgow \u00a0","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.V.","family":"McMurray","sequence":"additional","affiliation":[{"name":"Cardiology Department, Western Infirmary , Glasgow, G11 6NT ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.C.","family":"Connell","sequence":"additional","affiliation":[{"name":"Ninewells Hospital and Medical School , Dundee ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,2,18]]},"reference":[{"key":"2026020203272010100_ejhfhfr129-bib-0001","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1006\/jmcc.1993.1066","article-title":"Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism","volume":"25","author":"Brilla","year":"1993","journal-title":"J Mol Cell Cardiol"},{"key":"2026020203272010100_ejhfhfr129-bib-0002","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1006\/jmcc.1994.1098","article-title":"Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone","volume":"26","author":"Brilla","year":"1994","journal-title":"J Mol Cell Cardiol"},{"key":"2026020203272010100_ejhfhfr129-bib-0003","doi-asserted-by":"crossref","first-page":"H1802","DOI":"10.1152\/ajpheart.01096.2001","article-title":"Aldosterone induces a vascular inflammatory phenotype in the rat heart","volume":"283","author":"Rocha","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2026020203272010100_ejhfhfr129-bib-0004","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/01.HYP.24.5.571","article-title":"Chronic administration of aldosterone depresses baroreceptor reflex function in the dog","volume":"24","author":"Wang","year":"1994","journal-title":"Hypertension"},{"key":"2026020203272010100_ejhfhfr129-bib-0005","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1006\/jmcc.2002.2115","article-title":"Appraisal of the role of angiotensin II and aldosterone in ventricular myocyte apoptosis in adult normotensive rat","volume":"34","author":"De Angelis","year":"2002","journal-title":"J Mol Cell Cardiol"},{"key":"2026020203272010100_ejhfhfr129-bib-0006","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0002-9149(99)80353-1","article-title":"Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease","volume":"76","author":"Barr","year":"1995","journal-title":"Am J Cardiol"},{"key":"2026020203272010100_ejhfhfr129-bib-0007","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1161\/CIRCULATIONAHA.106.634626","article-title":"High plasma aldosterone levels on admission are associated with death in patients presenting with acute ST-elevation myocardial infarction","volume":"114","author":"Beygui","year":"2006","journal-title":"Circulation"},{"key":"2026020203272010100_ejhfhfr129-bib-0008","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1093\/eurheartj\/ehn383","article-title":"Plasma aldosterone levels during hospitalization are predictive of survival post-myocardial infarction","volume":"29","author":"Palmer","year":"2008","journal-title":"Eur Heart J"},{"key":"2026020203272010100_ejhfhfr129-bib-0009","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.amjcard.2010.04.019","article-title":"Usefulness of biomarker strategy to improve GRACE score's prediction performance in patients with non-ST-segment elevation acute coronary syndrome and low event rates","volume":"106","author":"Beygui","year":"2010","journal-title":"Am J Cardiol"},{"key":"2026020203272010100_ejhfhfr129-bib-0010","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.ahj.2008.12.013","article-title":"OPERA Investigators. Aldosterone and long-term outcome after myocardial infarction: a substudy of the French nationwide Observatoire sur la Prise en charge hospitali\u00e8re, l'Evolution \u00e0 un an et les caRact\u00e9ristiques de patients pr\u00e9sentant un infArctus du myocarde avec ou sans onde Q (OPERA) study","volume":"157","author":"Beygui","year":"2009","journal-title":"Am Heart J"},{"key":"2026020203272010100_ejhfhfr129-bib-0011","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/eurheartj\/ehq019","article-title":"Plasma aldosterone levels are associated with increased cardiovascular mortality: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study","volume":"31","author":"Tomaschitz","year":"2010","journal-title":"Eur Heart J"},{"key":"2026020203272010100_ejhfhfr129-bib-0012","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effects of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"4341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"2026020203272010100_ejhfhfr129-bib-0013","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"2026020203272010100_ejhfhfr129-bib-0014","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0140-6736(88)90742-8","article-title":"Localisation of 11 beta-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor","volume":"2","author":"Edwards","year":"1988","journal-title":"Lancet"},{"key":"2026020203272010100_ejhfhfr129-bib-0015","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1161\/CIRCULATIONAHA.106.653964","article-title":"Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure","volume":"115","author":"G\u00fcder","year":"2007","journal-title":"Circulation"},{"key":"2026020203272010100_ejhfhfr129-bib-0016","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0009-8981(77)90103-6","article-title":"Plasma cortisol, corticosterone and urea in acute myocardial infarction: clinical and biochemical correlations","volume":"76","author":"Wiener","year":"1977","journal-title":"Clin Chim Acta"},{"key":"2026020203272010100_ejhfhfr129-bib-0017","first-page":"8","article-title":"Correlation between cortisol levels and myocardial infarction mortality among intensive coronary care unit patients during first seven days in hospital","volume":"36","author":"Nito","year":"2004","journal-title":"Acta Med Indones"},{"key":"2026020203272010100_ejhfhfr129-bib-0018","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.ahj.2009.04.001","article-title":"Left ventricular remodeling after acute myocardial infarction: does eplerenone have an effect?","volume":"157","author":"Weir","year":"2009","journal-title":"Am Heart J"},{"key":"2026020203272010100_ejhfhfr129-bib-0019","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0009-8981(76)90505-2","article-title":"Simultaneous estimation of urinary steroids by semi-automated gas chromatography","volume":"69","author":"Shackleton","year":"1976","journal-title":"Clin Chim Acta"},{"key":"2026020203272010100_ejhfhfr129-bib-0020","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1161\/CIRCIMAGING.109.897439","article-title":"Microvascular obstruction remains a portent of adverse remodeling in optimally treated patients with left ventricular systolic dysfunction after acute myocardial infarction","volume":"3","author":"Weir","year":"2010","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026020203272010100_ejhfhfr129-bib-0021","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1161\/01.CIR.76.1.44","article-title":"Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction","volume":"76","author":"White","year":"1987","journal-title":"Circulation"},{"key":"2026020203272010100_ejhfhfr129-bib-0022","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1097\/HJH.0b013e3282e9a72d","article-title":"Spironolactone has antiarrhythmic activity in ischaemic cardiac patients without cardiac failure","volume":"25","author":"Shah","year":"2007","journal-title":"J Hypertens"},{"key":"2026020203272010100_ejhfhfr129-bib-0023","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1161\/HYPERTENSIONAHA.109.136242","article-title":"Glucorticoids activate cardiac mineralocorticoid receptors during experimental myocardial infarction","volume":"54","author":"Mihailidou","year":"2009","journal-title":"Hypertension"},{"key":"2026020203272010100_ejhfhfr129-bib-0024","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0167-5273(92)90201-D","article-title":"Serum cortisol levels predict infarct size and patient mortality","volume":"37","author":"Bain","year":"1992","journal-title":"Int J Cardiol"},{"key":"2026020203272010100_ejhfhfr129-bib-0025","doi-asserted-by":"crossref","first-page":"H647","DOI":"10.1152\/ajpheart.2001.281.2.H647","article-title":"Effect of a selective aldosterone receptor antagonist in myocardial infarction","volume":"281","author":"Delyani","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2026020203272010100_ejhfhfr129-bib-0026","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1161\/01.CIR.97.8.765","article-title":"Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction","volume":"97","author":"Wu","year":"1998","journal-title":"Circulation"},{"key":"2026020203272010100_ejhfhfr129-bib-0027","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1161\/01.CIR.0000068340.96506.0F","article-title":"Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction","volume":"107","author":"Hayashi","year":"2003","journal-title":"Circulation"},{"key":"2026020203272010100_ejhfhfr129-bib-0028","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/eurjhf\/hfp136","article-title":"Timing of eplerenone initiation and outcomes in patients with heart failure after acute myocardial infarction complicated by left ventricular systolic dysfunction: insights from the EPHESUS trial","volume":"11","author":"Adamopoulos","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"2026020203272010100_ejhfhfr129-bib-0029","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/eurjhf\/hfn015","article-title":"Anti-remodelling effect of canrenone in patients with mild chronic heart failure (AREA IN-CHF study): final results","volume":"11","author":"Boccanelli","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"2026020203272010100_ejhfhfr129-bib-0030","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.ahj.2010.06.049","article-title":"Rationale for an early aldosterone blockade in acute myocardial infarction and design of the ALBATROSS trial","volume":"160","author":"Beygui","year":"2010","journal-title":"Am Heart J"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1093%2Feurjhf%2Fhfr129","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/13\/12\/1305\/66468931\/eurjhf_13_12_1305.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/13\/12\/1305\/66468931\/eurjhf_13_12_1305.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T08:27:32Z","timestamp":1770020852000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/13\/12\/1305\/8430807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,1]]},"references-count":30,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2014,2,18]]},"published-print":{"date-parts":[[2011,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/eurjhf\/hfr129","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2011,12]]},"published":{"date-parts":[[2011,12,1]]}}}